E-resources
-
Cocco, Emiliano; Schram, Alison M; Kulick, Amanda; Misale, Sandra; Won, Helen H; Yaeger, Rona; Razavi, Pedram; Ptashkin, Ryan; Hechtman, Jaclyn F; Toska, Eneda; Cownie, James; Somwar, Romel; Shifman, Sophie; Mattar, Marissa; Selçuklu, S Duygu; Samoila, Aliaksandra; Guzman, Sean; Tuch, Brian B; Ebata, Kevin; de Stanchina, Elisa; Nagy, Rebecca J; Lanman, Richard B; Houck-Loomis, Brian; Patel, Juber A; Berger, Michael F; Ladanyi, Marc; Hyman, David M; Drilon, Alexander; Scaltriti, Maurizio
Nature medicine, 09/2019, Volume: 25, Issue: 9Journal Article
TRK fusions are found in a variety of cancer types, lead to oncogenic addiction, and strongly predict tumor-agnostic efficacy of TRK inhibition . With the recent approval of the first selective TRK inhibitor, larotrectinib, for patients with any TRK-fusion-positive adult or pediatric solid tumor, to identify mechanisms of treatment failure after initial response has become of immediate therapeutic relevance. So far, the only known resistance mechanism is the acquisition of on-target TRK kinase domain mutations, which interfere with drug binding and can potentially be addressable through second-generation TRK inhibitors . Here, we report off-target resistance in patients treated with TRK inhibitors and in patient-derived models, mediated by genomic alterations that converge to activate the mitogen-activated protein kinase (MAPK) pathway. MAPK pathway-directed targeted therapy, administered alone or in combination with TRK inhibition, re-established disease control. Experimental modeling further suggests that upfront dual inhibition of TRK and MEK may delay time to progression in cancer types prone to the genomic acquisition of MAPK pathway-activating alterations. Collectively, these data suggest that a subset of patients will develop off-target mechanisms of resistance to TRK inhibition with potential implications for clinical management and future clinical trial design.
Author
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.